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OBJECTIVE — Depression is common in patients with diabetes and is associated with worse
treatment outcomes. Its relationship to treatment adherence, however, has not been systemati-
cally reviewed. We used meta-analysis to examine the relationship between depression and
treatment nonadherence in patients with type 1 and type 2 diabetes.
RESEARCHDESIGNANDMETHODS — WesearchedMEDLINEandPsycINFOdata-
bases for all studies published by June 2007 and reviewed references of published articles.
Meta-analytic procedures were used to estimate the effect size r in a random effects model.
Signiﬁcance values, weighted effect sizes, 95% CIs, and tests of homogeneity of variance were
calculated.
RESULTS — Results from 47 independent samples showed that depression was signiﬁcantly
associated with nonadherence to the diabetes treatment regimen (z  9.97, P  0.0001). The
weighted effect size was near the medium range (r  0.21, 95% CI 0.17–0.25). Moderator
analyses showed that the effect was signiﬁcantly larger in studies that measured self-care as a
continuous versus categorical variable (P  0.001). Effect sizes were largest for missed medical
appointments and composite measures of self-care (r values  0.31, 0.29). Moderation analyses
suggest that effects for most other types of self-care are also near the medium range, especially in
studies with stronger methodologies.
CONCLUSIONS — These ﬁndings demonstrate a signiﬁcant association between depres-
sion and treatment nonadherence in patients with diabetes. Studies that used stronger method-
ologies had larger effects. Treatment nonadherence may represent an important pathway
between depression and worse diabetes clinical outcomes.
Diabetes Care 31:2398–2403, 2008
P
atients with diabetes are more likely
to experience depression than the
general population, and the pres-
ence of depression is associated with
poorer quality of life (1), increases in hy-
perglycemia (2), health care utilization
(3),riskofcomplications(4,5),functional
impairment (6), and risk of mortality (5).
The relationship between depression and
worse outcomes in diabetes could be ex-
plained, in part, through depression’s
relationship to poorer self-care and treat-
ment adherence. Meta-analysis has been
used to document a consistent relation-
ship between depression and hyperglyce-
mia (2) and depression and diabetes
complications (4). One meta-analysis has
documented a consistent relationship be-
tween depression and nonadherence to
medicaltreatmentin12studiesofdiverse
patient populations, but this meta-
analysisdidnotincludeanystudiesofpa-
tients with diabetes (7).
We surveyed the growing literature
on depression and treatment nonadher-
ence in patients with diabetes and per-
formed a meta-analysis to evaluate the
strength of this association. We examined
whether the association between depres-
sion and worse self-care varied as a func-
tion of the type of self-care assessed (i.e.,
composite measure of multiple self-care
behaviors, medical appointment atten-
dance, diet, medication adherence, exer-
cise, self-monitoring of blood glucose,
footcare).Wealsoexaminedwhetherthis
association differed by study population
because the behaviors involved in self-
care for type 1 diabetes are signiﬁcantly
different from type 2 diabetes and be-
cause children and adolescents are devel-
opmentallydifferentfromadultsandmay
be differentially sensitive to the effects of
depression. Finally, we sought to deter-
mine whether the depression-adherence
relationship differed depending on the
strength of study methodology, i.e., is the
relationship attenuated in more rigorous
studies or does stronger methodology re-
veal a larger relationship? Therefore, we
evaluated a set of potential moderators of
this relationship focusing on strength of
study methodology (i.e., different mea-
surement strategies and longitudinal ver-
sus cross-sectional designs).
RESEARCH DESIGN AND
METHODS
Sources of data and literature review
strategy
We searched the MEDLINE and Psy-
cINFO databases from 1950 through 1
June 2008 to identify all studies examin-
ing the relationship between depression
andself-careinpatientswithdiabetes.We
combinedthekeywords“diabetes”or“di-
abetes mellitus”; various synonyms for
compliance, adherence, self-care, and
self-management; and various terms re-
lated to depression or depressive symp-
toms. The reference lists from relevant
manuscripts were reviewed for additional
citations. In addition, we contacted the
corresponding author for each manu-
script retained for analysis to solicit addi-
tional articles. Corresponding authors
werealsoaskedtoidentifyotherresearch-
ers in the ﬁeld who might have applicable
articles;wethenqueriedtheseresearchers
with the same requests as noted above.
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Studies were limited to those 1) involving
children, adolescents, or adults with type
1 or type 2 diabetes where ﬁndings were
reported in English; 2) reporting sufﬁ-
cient data on the strength of the relation-
ship between depression and treatment
adherence to calculate an effect size; and
3) not involving any intervention that
could possibly affect the relationship be-
tween treatment adherence and depres-
sion because, as in the meta-analysis by
DiMatteo et al. (7), we sought to examine
a naturally occurring correlate of nonad-
herence. Treatment adherence was
broadlyoperationalizedtoincludeadher-
encetomedication,dietaryrecommenda-
tions, exercise, glucose monitoring, foot
self-care, scheduled medical appointments,
or any overall adherence composite mea-
sure. Depression was operationalized to in-
clude studies that used any measure that
had been developed speciﬁcally to assess
current depressive symptoms or diagnosis.
Study procedures
After the search was run, titles and ab-
stracts were reviewed by three coders
(E.M.C., L.A.M., and L.S.). Each coder
identiﬁed any abstract that he or she felt
might have assessed depression and dia-
betes self-care. Full-text manuscripts
were then obtained for these abstracts.
Thus, each abstract was reviewed at least
three times by independent coders, and
ﬁnal determinations about inclusion/
exclusionweremadeinconsultationwith
the primary author (J.S.G.) who reviewed
each manuscript in question. In addition
to the information needed to compute ef-
fect sizes, each manuscript was coded ac-
cording to self-care domain (medication,
diet, exercise, glucose monitoring, foot
care,attendanceatscheduledmedicalap-
pointments,oranoveralladherencecom-
posite measure); diabetes type (type 1 or
type 2); life stage (adult versus child/
adolescent);researchdesign(longitudinal
versuscross-sectional);levelofadherence
measurement (categorical versus contin-
uous); level of depression measurement
(categorical versus continuous); use of
validated measures versus nonvalidated
measures for depression; and use of ob-
jective versus nonobjective measures of
self-care.
For effects to be independent, each
study could contribute only one effect
sizeforeachmeta-analysis.Fortheoverall
analysis, when multiple types of diabetes
self-care were measured, we took the av-
erage of the effects. However, when sev-
eral different measures of the same
variable were available, we selected only
one effect. The general criterion we used
was to select the effect obtained by the
strongermethod,e.g.,weselectedcontin-
uous measures of depression or adher-
ence if data on both continuous and
dichotomized relationships were re-
ported in a single study, since it has been
demonstrated that dichotomizing contin-
uous variables causes the estimation of
the population correlation to be system-
atically reduced in magnitude and re-
ducespower(8,9).Ifsamplesizesdiffered
for different measures, we used the mea-
sures that had a larger sample size
(10,11). One study reported both self-
reported and caregiver reported data for
depression and self-care; we used self-
reporteddatafortheanalysis(12).Where
two papers were published from samples
that were not independent, we included
the article with the stronger design: lon-
gitudinal over cross-sectional (13,14) or
larger sample (15,16). Finally, one study
measured depression as both a diagnosis
based on structured interview and as a
comparison based on the total score from
the Centers for Epidemiological Studies
Depression Scale (CESD) using two dif-
ferent cutoffs (16 or 22) (17). Because an
average of the effect sizes would not be
appropriate, and there was no intrinsic
differenceinstrengthofmethodology,we
chose the data based on the CESD cut
point of 22. Using data based on the
CESDcutoffof16orthediagnosisdidnot
alter any of our results (data not shown).
Statistical analysis
We followed the meta-analytic proce-
dures of Lipsey and Wilson (18). The ef-
fect size r was used. When r or phi
statistics were not provided, we com-
puted r from means and SDs, odds ratios,
t tests, 
2, F, contingency table data, or
exactPvalues.WhenmeansandSDswere
reported for more than two groups (e.g.,
adherence scores for low, intermediate,
and high depression), we based our effect
sizecalculationsoncomparisonsbetween
the two most extreme groups. When
studies presented effect sizes that had
more than 1 d.f., we ( J.S.G., M.M.) con-
tacted authors to obtain bivariate data.
However, because it has been demon-
strated that r can be accurately estimated
from -coefﬁcients in multiple regres-
sion, even when covariates are present,
we estimated r in one case (i.e., 19) using
the formula r  0.980.05, where 
isanindicatorvariablethatequals1when
isnonnegativeand0whenisnegative
(20).
We report effect sizes based on the
random effects model and used a fully
random effects analysis to examine mod-
erators. Effect sizes are weighted by the
inverse variance of each study, which is
determined primarily by sample size but
also takes into account other factors that
affect the precision of the effect size (18).
All computations were based on Fisher z
transformations of r. Meta-analytic soft-
ware (Comprehensive Meta-Analysis 2.0)
was used to calculate average z scores and
Pvalues,weightedeffectsizervalues,and
the 95% CI around the collective effect
size values.
We evaluated the signiﬁcance of vari-
ability among effect sizes by calculating
theQstatisticandquantiﬁedthedegreeof
dispersion of effect sizes with an I-
squared index, which serves as a ratio of
the variance between studies to total vari-
ance (21). We also used the software to
examine whether the effect size differed
signiﬁcantly across levels of the potential
moderators of the depression-adherence
relationship. We performed tests of mod-
eration for the overall analysis and within
each type of self-care behavior, if the re-
sults displayed signiﬁcant heterogeneity
and the number of studies was adequate.
Because examination of moderation in
meta-analysis requires that the effects in
each group be independent, we were un-
able to conduct moderation analyses for
type of self-care behavior because most
studies measured more than one type of
self-care. However, we present results
of separate meta-analyses for each type of
self-care behavior. For these analyses, the
same study could be counted in multiple
categories of self-care because the effects
were independent within each category.
Because “the ﬁle drawer problem,” or
the selective publishing of signiﬁcant
ﬁndings and the disproportionate exclu-
sion of nonsigniﬁcant ﬁndings from pub-
lication, can be a problem in generalizing
the results of meta-analysis, we also cal-
culated the “fail-safe n” for each grouped
effect size (22), reﬂecting the number of
unpublished studies necessary to reduce
the obtained effect size to nonsigniﬁ-
cance.Wealsoprovidethenumberofun-
published studies with a mean effect size
of r  0.00 that would be required to
reduce the effect size below the r  0.05
level, chosen as an effect size that would
be trivial (23). Cohen (24) has suggested
that, in behavioral science research, ef-
fects can be considered small when r 
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when r  0.40.
RESULTS
Overall analysis
A total of 47 independent study samples,
including 17,319 participants from 43
published reports (see online appendix at
http://dx.doi.org/10.2337/dc08–1341),
met our inclusion criteria. The character-
istics and ﬁndings of these studies are
summarized in the online appendix. The
studies used a variety of measures, meth-
ods, samples, and analytical approaches.
Meta-analysis revealed a signiﬁcant asso-
ciation between depression and poorer
self-care (P  0.0001) and a weighted ef-
fect size (r  0.21, 95% CI 0.17–0.25),
which places the effect near the bench-
mark of r  0.25 for a medium-sized ef-
fect (24). The “fail-safe n” for the number
of unpublished studies with null ﬁnd-
ings required to bring this effect to non-
signiﬁcance is 4,997. Orwin’s fail-safe n
for the number of studies required to
bring the effect size below r  0.05 is
152 (see ﬁrst data row in Table 1).
Analyses by type of self-care
We also ran our analyses aggregating
studies by type of diabetes self-care and
performed separate meta-analyses for
each grouping. For these analyses, 88
effects were distributed across seven
categories of diabetes self-care (Table
1). The effect of depression and self-
care varied across types of self-care be-
haviors, with the strongest effect size
found for missed medical appointments
(k  4, r  0.31, 95% CI 0.29–0.34)
and the smallest effect size found for
foot care (k  2, r  0.07, 0.08–
0.21), which was nonsigniﬁcant.
Moderation analyses
We examined potential moderators of the
effects for the overall analysis and speciﬁc
self-care domains when signiﬁcant heter-
ogeneity was present. Because the effects
for missed medical appointments and ex-
ercise were not heterogeneous, modera-
torswerenotexamined.Becauseonlytwo
studies measured foot care, we could not
performamoderatoranalysisforthisvari-
able. We found no signiﬁcant moderators
for composite measures.
As can be seen in Table 2, the only
effect moderation for type of study popu-
lationwasthatstudiesofchildrenandad-
olescents obtained signiﬁcantly larger
effects for glucose monitoring than those
of adults; although the pattern in the
overall analysis was similar, it did not
reach statistical signiﬁcance (P  0.064).
In contrast, there were multiple method-
ological moderators of effect sizes. Longi-
tudinal studies found signiﬁcantly larger
effects for diet than cross-sectional stud-
ies. Studies that measured and analyzed
adherence as a continuous variable found
signiﬁcantly larger effects in the overall
analysis, for medication adherence, and
for glucose self-monitoring than those
that measured adherence as a categorical
Table 1—Meta-analysis results aggregated by type of self-care
nz (P) Weighted r 95% CI Heterogeneity Q (df) and I
2
Fail-safe n
(r  0.05)
Overall analysis 47 9.81 (0.001) 0.21 0.17–0.25 217.66 (46); P  0.001; I
2  78.87 149
Appointment keeping 4 21.58 (0.001) 0.31 0.29–0.34 1.79 (3); P  0.617; I
2  0.00 22
Composite measures 18 9.66 (0.001) 0.29 0.23–0.34 38.60 (17); P  0.002; I
2 55.96 88
Diet 18 7.60 (0.001) 0.18 0.13–0.22 33.67 (17); P  0.009; I
2  49.51 37
Medication 18 5.15 (0.001) 0.14 0.09–0.20 49.73 (16); P  0.001; I
2  65.82 24
Exercise 13 7.89 (0.001) 0.14 0.10–0.17 14.43 (12); P  0.274; I
2  16.86 22
Glucose monitoring 15 3.50 (0.001) 0.10 0.04–0.16 31.00 (14); P  0.006; I
2  54.82 4
Foot care 2 0.88 (0.380) 0.07 0.08 to 0.21 4.27 (1); P  0.039; I
2  76.59 NA
Table 2—Moderation analyses: signiﬁcant results
Moderators Domain (P) Subcategory analyses
Methodology: longitudinal (L) vs. cross-sectional (C) Diet (0.021) L: (k  2; r  0.28; 95% CI 0.18–0.37);
C: (k  16; r  0.15; 0.11–0.19)
Self-care continuous (Con) vs. categorical (Cat) Overall analysis (0.001) Con: (k  32; r  0.24; 0.21–0.28);
Cat: (k  14; r  0.13; 0.07–0.18)
Medication (0.011) Con: (k  9; r  0.20; 0.14–0.27);
Cat: (k  9; r  0.09; 0.03–0.15)
Glucose monitoring (0.010) Con: (k  9; r  0.15; 0.09–0.22);
Cat: (k  6; r  0.03; 0.03–0.10)
Objective measure of self-care (O) vs. non-objective measure (N) Glucose monitoring (0.036) O: (k  2; r  0.22; 0.09–0.35);
N: (k  13; r  0.07; 0.02–0.12)
Population: youth (Y) vs. adults (A) Overall analysis (0.064) Y: (k  10; r  0.29; 0.20–0.37);
A: (k  37; r  0.19; 0.15–0.24)
Glucose monitoring (0.023) Y: (k  3; r  0.27; 0.11–0.41);
A: (k  12; r  0.08; 0.02–0.13)
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sures of self-care (i.e., electronically
downloaded data) found signiﬁcantly
stronger effects for monitoring than those
that used other assessment methods.
CONCLUSIONS — The results of
this meta-analysis, based on 47 indepen-
dent samples totaling over 17,000 pa-
tients, suggest that depression is
signiﬁcantly associated with nonadher-
ence to diabetes self-care with an effect of
moderate strength relative to the range of
effect sizes typical in the social sciences.
The size of this overall effect (r  0.21)
is identical to the effect (r weighted by
n30.21)obtainedbyDiMatteoetal.
(7) based on a meta-analysis of 12 studies
of patients adhering to treatment regi-
mensofotherchronicillnesses.Theeffect
is also similar in magnitude to the effects
obtained from meta-analyses of the rela-
tionship between depression and hyper-
glycemia (r  0.17) (2) and between
depression and diabetes complications
(r  0.25) (4). To the extent that self-care
is causally related to hyperglycemia and
diabetes complications, our results sug-
gest that impairment in self-care may be
onepathwaythroughwhichdepressionis
associated with these negative health out-
comes in patients with diabetes.
We found that the relationship be-
tween depression and worse self-care dif-
fered depending on the type of self-care
measured. The effect was strongest and
homogeneous for studies of missed med-
ical appointments. Adherence to this type
of self-care is unique in that it requires
interpersonal behavior. Clinically, de-
pression is associated with impairments
in interpersonal behavior such as social
withdrawal, disengagement from impor-
tant activities, avoidance, and often with
disruption of interpersonal relationships.
Patients with increased levels of depres-
sion have been shown to report more dis-
satisfaction with their providers (27).
Considering that missed appointments
are also often associated with increased
provider frustration (28), decreased em-
pathy and patient-provider communica-
tion (29), and less continuity of care (29),
this relationship may have important
ramiﬁcations for depressed patients with
diabetes.
Studiesthatusedcompositemeasures
ofdiabetesself-carethattappedintomore
than one aspect of self-care also found
stronger effects. This may be because
comprehensivemeasuresaremorerobust
methodologically, or because the effects
ofdepressionaremoreglobalandarebet-
ter captured by a more global measure of
self-care. Although we found somewhat
weaker relationships between depression
anddietandmedicationadherence,stud-
iesthatusedstrongermethodologyfound
larger effects. If these effects (r values 
0.20–0.28) are considered to be the best
estimatesofthetrueeffect,thenitappears
that the effects on diet and medication
adherence are also in the moderate range.
Surprisingly, the relationship between
depression and exercise was relatively
weaker and homogenous. The effect for
self-monitoring of blood glucose was
small,butstudiesthatmeasuredmonitor-
ing as a continuous variable found signif-
icantly stronger effects. Also, the two
studies (25,26) that used objective mea-
sures of glucose monitoring found signif-
icantlystrongereffectsthanthosethatdid
not, and the weighted average of these ef-
fects (r  0.22) was near the medium ef-
fectsizebenchmark.Finally,footcarewas
not signiﬁcantly related to depression
overall. However, only 2 of 47 effects
measured foot care, which suggests this
aspect of self-care may not be given sufﬁ-
cientattentioninresearchorinproviders’
instructions to patients.
With regard to population modera-
tors, we examined differences between
type 1 and type 2 diabetes and between
children/adolescents and adults. We fo-
cused on these contrasts because it was
plausible to expect that self-care routines
are sufﬁciently different between these
groups so as to affect the relationship be-
tweendepressionandself-care.Wefound
no evidence to suggest that the relation-
ship between depression and self-care
varied as a function of type of diabetes.
We did ﬁnd that studies of children and
adolescents tended to report larger effects
than studies of adults, although effects in
both populations were signiﬁcant. This
ﬁnding could also support more research
on the impact of depression on diabetes
self-careinchildrenandadolescents,par-
ticularly for self-monitoring of blood glu-
cose. We are unaware of depression
treatmentinterventionsthathavetargeted
children or adolescents with diabetes to
examine impacts on self-care or control.
Our results suggest that, if the relation-
ship between depression and worse self-
care is causal, interventions in youth may
have more of an impact on diabetes self-
care and control than interventions with
adults.
The results of this meta-analysis also
provide important information on the
methodological moderators of the effect
between depression and diabetes self-
care.Wedidnotﬁndanyevidencetosug-
gest that studies using stronger
methodology found weaker effects; to the
contrary, the effects were signiﬁcantly
larger when stronger methods were used.
This was especially true for studies that
analyzed self-care as a continuous vari-
able: larger effects were obtained in the
overall analysis, for medication adher-
ence, and for glucose monitoring. Signif-
icantly larger effects for diet were also
found in studies that used longitudinal
designs. Also, studies that used objective
measures of glucose monitoring found
signiﬁcantly stronger effects than those
thatreliedonself-reportorothermethods
more vulnerable to bias. Further, in the
analyses aggregated by type of self-care,
the strongest effects were found for ap-
pointment keeping, and each of the stud-
ies that measured this type of self-care
usedobjectivemethodstomeasureit(i.e.,
medical records data). Thus, assuming
that studies that use more rigorous meth-
ods will provide more accurate estimates
of the true effect, it appears that our over-
all effect of r  0.21 may actually under-
estimate the true association between
depression and poorer self-care.
Future studies could be improved by
using more rigorous measures and avoid-
ing dichotomization of variables. The
question of dichotomization is not only a
statistical consideration that reduces
power and accuracy (8); it also reﬂects a
limitation in the conceptualization of de-
pressionandadherenceaspurelycategor-
icalconstructs.Forexample,inaprevious
article based on a large sample of primary
care patients with type 2 diabetes, we
showed that the relationship between de-
pressive symptoms and worse diabetes
self-care was not limited to patients likely
to meet diagnostic criteria for major de-
pressive disorder. We found the same
magnitude of effects between symptoms
ofdepressionandworseself-careinasub-
sample of patients who did not meet
screening criteria for major depressive
disorder as we did in the overall sample
(13). These ﬁndings, along with the re-
sults of this meta-analysis, suggest that it
would be inaccurate to think that the re-
lationship between symptoms of depres-
sion and poorer diabetes self-care is
limited to those who have clinically sig-
niﬁcantlevelsofdepression.Rather,itap-
pears that increases in depressive
symptoms (measured by a variety of
methods) are incrementally associated
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would also argue, both on conceptual
grounds and based on the results of our
moderation analyses, that it is also inac-
curate to conceptualize self-care adher-
ence as a categorical construct and to
think of “adherent” versus “nonadherent”
patients.
The results of this meta-analysis may
have implications for patient interven-
tions.Itshouldbestatedattheoutsetthat
noneofthestudiesreviewedhereprovide
conclusive evidence that the relationship
between depression and poorer diabetes
self-care is causal. However, one study
used a longitudinal design and found sig-
niﬁcant relationships between depressive
symptoms at baseline and increases in
symptoms of depression over time and a
variety of self-care behaviors assessed 9
monthslater,evenwhenbaselinelevelsof
self-care were controlled (14). Another
study of an open-label treatment trial of
bupropionhydrochlorideinpatientswith
type 2 diabetes and major depressive dis-
order found that depression severity,
BMI, total fat mass, and A1C decreased
during the acute phase of treatment,
whereas adherence to diet and exercise
improved signiﬁcantly (30). The pattern
of ﬁndings from these studies is consis-
tent with a causal relationship but does
notprovideconclusiveproof.Thecurrent
meta-analysis excluded randomized con-
trolled trials, which would provide the
strongest causal evidence, because we
soughttoevaluatethenaturallyoccurring
relationship between depression and
poorer self-care, without the inﬂuence of
intervention. Yet, evidence from random-
izedcontrolledtrialssuggestingthattreat-
ing depression in patients with diabetes
has positive effects on diabetes self-care
hasbeenlacking.Trialsofantidepressants
(31,32), cognitive behavioral therapy
(33), and stepped-care case management
(34–36) have had positive effects on de-
pression but have generally failed to have
a positive impact on self-care behaviors.
However, these trials have avoided inte-
gration of diabetes self-management
training with the treatment of depression
to isolate the effect of treating depression
alone on diabetes outcomes.
The limitations of the available inter-
vention literature suggest there may be an
opportunitytomaximizeeffectsondiabe-
tes control by developing comprehensive
interventions to improve both depression
andself-care(37).Itmaybenecessarybut
not sufﬁcient to treat depression to im-
prove self-care in patients who are strug-
gling with depression and problems with
diabetes self-management. Comprehen-
sive interventions that address both self-
care and depression management are
likely to be more successful, and guide-
lines for how such interventions may be
implemented in practice have been pro-
posed (38). Because even nonclinical lev-
els of depressive symptoms can be
associated with nonadherence (13) and
areassociatedwithsigniﬁcantincreasesin
risk for complications, functional impair-
ment,anddeath(5),perhapsallinterven-
tions oriented toward self-care or
adherence should include a component
to address psychological/emotional dis-
tress. Previous research has shown that
such integrated programs can have posi-
tive effects on both self-care and emo-
tional distress (39,40). Taken together
with the ﬁndings of this meta-analysis,
this work could guide the design of well-
powered randomized controlled trials of
such interventions.
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